How big is the Recombinant Protein Market?

The Recombinant Protein Market size is expected to reach USD 2.69 billion in 2024 and grow at a CAGR of 7.91% to reach USD 3.94 billion by 2029. Read More

What is the current Recombinant Protein Market size?

In 2024, the Recombinant Protein Market size is expected to reach USD 2.69 billion. Read More

Who are the key players in Recombinant Protein Market?

Eli Lilly and Company, Thermo Fisher Scientific Inc., Novartis AG, GlaxoSmithKline PLC and Pfizer Inc. are the major companies operating in the Recombinant Protein Market. Read More

Which is the fastest growing region in Recombinant Protein Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Recombinant Protein Market?

In 2024, the North America accounts for the largest market share in Recombinant Protein Market. Read More

What years does this Recombinant Protein Market cover, and what was the market size in 2023?

In 2023, the Recombinant Protein Market size was estimated at USD 2.49 billion. The report covers the Recombinant Protein Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Recombinant Protein Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Recombinant Protein Market Share

Statistics for the 2023 & 2024 Recombinant Protein market share, created by Mordor Intelligence™ Industry Reports. Recombinant Protein share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Recombinant Protein Industry

The recombinant protein market is moderately competitive due to the presence of a few companies operating globally and regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold market shares and are well known, such as Abbvie Inc., Amgen Inc., Bio-Rad Laboratories Inc., Eli Lilly and Company, Merck KGaA, Novo Nordisk AS, Sanofi SA, Thermo Fisher Scientific Inc., Novartis AG, GlaxoSmithKline PLC, Novavax Inc., GigaGen Inc., and Pfizer Inc.